{"id":"https://openalex.org/W4361947239","doi":"https://doi.org/10.1158/1078-0432.c.6530420","title":"Data from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations","display_name":"Data from Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361947239","doi":"https://doi.org/10.1158/1078-0432.c.6530420"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6530420","doi":"https://doi.org/10.1158/1078-0432.c.6530420","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530420","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6530420","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065302418","display_name":"Elio Adib","orcid":"https://orcid.org/0000-0003-0594-7976","observed_orcids":["https://orcid.org/0000-0003-0594-7976"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elio Adib","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037157502","display_name":"Katarzyna Klonowska","orcid":"https://orcid.org/0000-0001-9494-8801","observed_orcids":["https://orcid.org/0000-0001-9494-8801"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katarzyna Klonowska","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103273591","display_name":"\u039a\u03c1\u03b9\u03bd\u03b9\u03ce \u0393\u03b9\u03b1\u03bd\u03bd\u03af\u03ba\u03bf\u03c5","orcid":"https://orcid.org/0000-0003-2695-4606","observed_orcids":["https://orcid.org/0000-0003-2695-4606"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krinio Giannikou","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027987889","display_name":"Khanh T. Do","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khanh T. Do","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053615734","display_name":"Solida Pruitt-Thompson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Solida Pruitt-Thompson","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041064192","display_name":"Ketki Bhushan","orcid":"https://orcid.org/0009-0007-8625-1677","observed_orcids":["https://orcid.org/0009-0007-8625-1677"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ketki Bhushan","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060316199","display_name":"Matthew I. Milstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew I. Milstein","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042257399","display_name":"Jennifer Hedglin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Hedglin","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020514403","display_name":"Katherine E. Kargus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine E. Kargus","raw_affiliation_strings":["Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090956629","display_name":"Lynette Marie Sholl","orcid":"https://orcid.org/0000-0002-9532-9735","observed_orcids":["https://orcid.org/0000-0002-9532-9735"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynette M. Sholl","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":"https://orcid.org/0000-0002-9532-9735","affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041089077","display_name":"Junko Tsuji","orcid":"https://orcid.org/0000-0003-0139-3750","observed_orcids":["https://orcid.org/0000-0003-0139-3750"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junko Tsuji","raw_affiliation_strings":["Genomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genomics Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068193017","display_name":"David Michael Hyman","orcid":"https://orcid.org/0000-0001-8150-9762","observed_orcids":["https://orcid.org/0000-0001-8150-9762"]},"institutions":[{"id":"https://openalex.org/I4210132618","display_name":"Loxo Oncology at Lilly (United States)","ror":"https://ror.org/03abe5304","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Hyman","raw_affiliation_strings":["Loxo Oncology at Lilly, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Loxo Oncology at Lilly, New York, New York","institution_ids":["https://openalex.org/I4210132618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012514612","display_name":"Anne Sisk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Sisk","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","Genitourinary Oncology Service,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Genitourinary Oncology Service,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045419282","display_name":"Geoffrey Ira Shapiro","orcid":"https://orcid.org/0000-0002-3331-4095","observed_orcids":["https://orcid.org/0000-0002-3331-4095"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey I. Shapiro","raw_affiliation_strings":["Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002973886","display_name":"Hebert Alberto Vargas","orcid":"https://orcid.org/0000-0003-1169-133X","observed_orcids":["https://orcid.org/0000-0003-1169-133X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hebert A. Vargas","raw_affiliation_strings":["Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York","Weil Cornell Medical College, New York, New York"],"raw_orcid":"https://orcid.org/0000-0003-1169-133X","affiliations":[{"raw_affiliation_string":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weil Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065435809","display_name":"James J. Harding","orcid":"https://orcid.org/0000-0002-7029-4310","observed_orcids":["https://orcid.org/0000-0002-7029-4310","https://orcid.org/0000-0003-0766-9965"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James J. Harding","raw_affiliation_strings":["Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, New York","Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","Weil Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weil Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859782","display_name":"Martin Henner Voss","orcid":"https://orcid.org/0000-0003-0551-5807","observed_orcids":["https://orcid.org/0000-0003-0551-5807"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin H. Voss","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","Genitourinary Oncology Service,","Weil Cornell Medical College, New York, New York"],"raw_orcid":"https://orcid.org/0000-0003-0551-5807","affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Genitourinary Oncology Service,","institution_ids":[]},{"raw_affiliation_string":"Weil Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064203357","display_name":"Gopa Iyer","orcid":"https://orcid.org/0000-0002-5093-6099","observed_orcids":["https://orcid.org/0000-0002-5093-6099"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gopa Iyer","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","Genitourinary Oncology Service,","Weil Cornell Medical College, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Genitourinary Oncology Service,","institution_ids":[]},{"raw_affiliation_string":"Weil Cornell Medical College, New York, New York","institution_ids":["https://openalex.org/I205783295"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100620133","display_name":"David J. Kwiatkowski","orcid":"https://orcid.org/0000-0002-5668-5219","observed_orcids":["https://orcid.org/0000-0002-5668-5219"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Kwiatkowski","raw_affiliation_strings":["Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,"],"raw_orcid":"https://orcid.org/0000-0002-5668-5219","affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachu-setts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.026799999177455902,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/tsc1-mutation","display_name":"TSC1 mutation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/tsc2-mutation","display_name":"TSC2 mutation","score":1.0},{"id":"https://openalex.org/keywords/mtor-mutations","display_name":"mTOR mutations","score":0.9919999837875366},{"id":"https://openalex.org/keywords/mtorc1-inhibitors","display_name":"mTORC1 inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.972000002861023},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.7680000066757202},{"id":"https://openalex.org/keywords/upper-tract-urothelial-carcinoma","display_name":"upper tract urothelial carcinoma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/uterine-carcinoma","display_name":"uterine carcinoma","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.8230000138282776},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.609000027179718}],"concepts":[{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8397242426872253},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6751957535743713},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.5573315024375916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5301764011383057},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48310303688049316},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41515910625457764},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4096132516860962},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3451319932937622},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.17275068163871765}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6530420","doi":"https://doi.org/10.1158/1078-0432.c.6530420","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530420","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6530420","doi":"https://doi.org/10.1158/1078-0432.c.6530420","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6530420","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2051006376","display_name":null,"funder_award_id":"CA008748","funder_id":"https://openalex.org/F4320309468","funder_display_name":"Memorial Sloan-Kettering Cancer Center"},{"id":"https://openalex.org/G289723095","display_name":null,"funder_award_id":"P30\u00a0CA008748","funder_id":"https://openalex.org/F4320309468","funder_display_name":"Memorial Sloan-Kettering Cancer Center"}],"funders":[{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1985754630","https://openalex.org/W1988303870","https://openalex.org/W1999582874","https://openalex.org/W1999999605","https://openalex.org/W2001968573","https://openalex.org/W2004809400","https://openalex.org/W2017018900","https://openalex.org/W2019607817","https://openalex.org/W2029818855","https://openalex.org/W2067286988","https://openalex.org/W2086528604","https://openalex.org/W2097426323","https://openalex.org/W2109038438","https://openalex.org/W2115045760","https://openalex.org/W2115686439","https://openalex.org/W2134749898","https://openalex.org/W2139802897","https://openalex.org/W2163583831","https://openalex.org/W2253928581","https://openalex.org/W2263864814","https://openalex.org/W2335738552","https://openalex.org/W2551013093","https://openalex.org/W2593030814","https://openalex.org/W2613362156","https://openalex.org/W2770026599","https://openalex.org/W2890901132","https://openalex.org/W2896869836","https://openalex.org/W2907956840","https://openalex.org/W2941119008","https://openalex.org/W2949857618","https://openalex.org/W2952136072","https://openalex.org/W2982276713","https://openalex.org/W4246883504","https://openalex.org/W4250337897","https://openalex.org/W4251731689"],"related_works":["https://openalex.org/W3135968763","https://openalex.org/W3175028012","https://openalex.org/W4361939000","https://openalex.org/W2600562653","https://openalex.org/W4361939130","https://openalex.org/W3161705542","https://openalex.org/W2970866199","https://openalex.org/W2802855637","https://openalex.org/W3168759868","https://openalex.org/W4238518604"],"abstract_inverted_index":{"AbstractPurpose:":[0],"This":[1],"was":[2,74,81,133,158,170,178],"a":[3,229],"multicenter,":[4],"histology-agnostic,":[5],"single-arm":[6],"prospective":[7],"phase":[8],"II":[9],"trial":[10],"of":[11,14,130,204],"therapeutic":[12],"activity":[13],"everolimus,":[15],"an":[16],"oral":[17],"mTORC1":[18],"inhibitor,":[19],"in":[20,46,146,233],"patients":[21,96,148,191],"with":[22,36,38,59,192,201,217],"advanced":[23],"solid":[24],"tumors":[25,37],"that":[26],"harbored":[27,110],"TSC1/TSC2":[28,40],"or":[29,41,68,120],"MTOR":[30,43,121],"mutations.":[31,123],"Patients":[32,35,56],"and":[33,92,103,117,165,186,206,211,221,244],"Methods:":[34],"inactivating":[39],"activating":[42],"mutations":[44,220],"identified":[45],"any":[47,131],"Clinical":[48],"Laboratory":[49],"Improvement":[50],"Amendments":[51],"(CLIA)-certified":[52],"laboratory":[53],"were":[54,57,97,144],"eligible.":[55],"treated":[58],"everolimus":[60],"10":[61],"mg":[62],"once":[63],"daily":[64],"until":[65],"disease":[66],"progression":[67],"unacceptable":[69],"toxicity.":[70],"The":[71,124],"primary":[72],"endpoint":[73],"objective":[75,193],"response":[76],"rate":[77],"(ORR).":[78],"Whole-exome":[79],"sequencing":[80],"performed":[82],"to":[83],"identify":[84],"co-occurring":[85],"genomic":[86,184],"alterations.":[87],"Results:":[88],"Between":[89],"November":[90],"2015":[91],"October":[93],"2018,":[94],"30":[95],"enrolled":[98],"at":[99],"Dana-Farber":[100],"Cancer":[101,107],"Institute":[102],"Memorial":[104],"Sloan":[105],"Kettering":[106],"Center.":[108],"Tumors":[109],"TSC1":[111,116,205],"(13/30),":[112],"TSC2":[113,118],"(15/30),":[114],"concurrent":[115],"(1/30),":[119],"(1/30)":[122],"most":[125],"common":[126],"treatment-related":[127],"adverse":[128],"event":[129],"grade":[132],"mucositis":[134],"(8/30,":[135],"27%);":[136],"1":[137,195],"patient":[138],"had":[139,196,214,228],"fatal":[140],"pneumonitis.":[141],"Partial":[142],"responses":[143],"seen":[145],"2":[147,190],"[7%;":[149],"95%":[150],"confidence":[151],"interval":[152],"(CI),":[153],"1%\u201322%].":[154],"Median":[155],"progression-free":[156],"survival":[157,168],"2.3":[159],"months":[160,172],"(95%":[161,173],"CI,":[162,174],"1.8\u20133.7":[163],"months)":[164],"median":[166],"overall":[167],"(OS)":[169],"7.3":[171],"4.5\u201312.7":[175],"months).":[176],"There":[177],"no":[179],"clear":[180],"association":[181],"between":[182],"other":[183,213],"alterations":[185],"response.":[187],"Of":[188],"the":[189,212],"response,":[194],"upper":[197],"tract":[198],"urothelial":[199],"carcinoma":[200,216],"biallelic":[202,218],"inactivation":[203],"high":[207],"tumor":[208],"mutation":[209],"burden,":[210],"uterine":[215],"TSC2-inactivating":[219],"PEComa-like":[222],"pathologic":[223],"features.":[224],"Conclusions:":[225],"Everolimus":[226],"therapy":[227],"disappointing":[230],"ORR":[231],"(7%)":[232],"this":[234],"pan-cancer,":[235],"mutation-selected,":[236],"basket":[237],"study.":[238],"See":[239],"related":[240],"commentary":[241],"by":[242],"Kato":[243],"Cohen,":[245],"p.":[246],"3807":[247]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-04-05T00:00:00"}
